Schmidt-Hegemann et al. [12] showed in 129 patients who underwent PSMA PET before sRT for PCa recurrence that PSMA PET-based RT is an efficacy salvage treatment, being able to maintain a period of PSA-free relapse similar to that provided by ADT. Here, KLK3 is linked to posterior cortical atrophy.